EDGE MEDICAL-B (02675): On October 28, 2026, Jianchen Wang was deemed to have acquired an interest in 300,000 H shares following the issuer’s on-market repurchase under the repurchase mandate at an average of HKD 33.3034 per share (total consideration about HKD 9.99 million). The repurchased shares were held as treasury shares. The transaction took place on-exchange on the SEHK.
Prior to the acquisition, Jianchen Wang’s long position in EDGE MEDICAL-B was 124.01 million shares, representing 37.83%; following the acquisition, the holding changed to 124.31 million shares, with the long position ratio rising to 37.93%.
Source: Hong Kong Exchanges and Clearing Limited.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments